Company: LHI
Filing Date: 2025-08-08
Form Type: F-1/A
Source: 0001213900-25-073646
Chunk: 97

Company: Living Homeopathy International Ltd.
Filing Date: 2025-08-08
Form: F-1/A
Chunk 97
---
ilution results from the fact that the initial public offering price per Ordinary Share is substantially in excess of the net
tangible book value per Ordinary Share attributable to the existing shareholders for our presently outstanding Ordinary
Shares.

Living Homeopathy’s net tangible book
value as of March 31, 2025 was approximately $2,946,934, or $0.33 per Class A Ordinary Share. Net tangible book value represents the
amount of Living Homeopathy’s total consolidated tangible assets, less the amount of Living Homeopathy’s total consolidated
liabilities. Dilution is determined by subtracting the as adjusted net tangible book value per Class A Ordinary Share from the initial
public offering price per Class A Ordinary Share and after deducting the estimated discounts to the underwriter and the estimated offering
expenses payable by Living Homeopathy.

Dilution to New Investors if the Offering Amount is Sold without Exercise of the Over-allotment Option

After giving further effect to Living Homeopathy’s
sale of 1,250,000 Class A Ordinary Shares in this offering at the assumed public offering price of $5.00 per Class A Ordinary Share,
which is the midpoint of the price range set forth on the cover page of this prospectus, and after deducting estimated offering expenses
payable by Living Homeopathy, Living Homeopathy’s pro forma as adjusted net tangible book value as of March 31, 2025 is $7,012,634,
or $0.68 per Class A Ordinary Share. This represents an immediate increase in as adjusted net tangible book value per Class A Ordinary
Share of $0.36 to our existing stockholders and an immediate dilution in as adjusted net tangible book value per Class A Ordinary Share
of $4.32 to new investors purchasing Class A Ordinary Shares in this offering.

The following table illustrates this dilution:

| Assumed initial public offering price per Class                     
 A Ordinary Share                                                    |     | $ | 5.00 |
| Net tangible book value per Ordinary Share as of March 31, 2025     |     | $ | 0.33 |
| Increase in net tangible book value per Ordinary Share attributable 
 to payments by new investors                                        |     | $ | 0.36 |
| As adjusted net tangible book value per Ordinary Share immediately  
 after this offering                                                 |     | $ | 0.68 |
| Amount of dilution in net tangible book value per Ordinary          
 Share to new investors in the offering                              |     | $ | 4.32